BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 24807556)

  • 1. Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection.
    Agrawal AS; Ying T; Tao X; Garron T; Algaissi A; Wang Y; Wang L; Peng BH; Jiang S; Dimitrov DS; Tseng CT
    Sci Rep; 2016 Aug; 6():31629. PubMed ID: 27538452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).
    Sakamoto S; Tanaka H; Morimoto S
    Ann Transl Med; 2015 Mar; 3(3):35. PubMed ID: 25815296
    [No Abstract]   [Full Text] [Related]  

  • 3. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
    Desforges M; Le Coupanec A; Dubeau P; Bourgouin A; Lajoie L; Dubé M; Talbot PJ
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31861926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MERS-coronavirus: From discovery to intervention.
    Widagdo W; Okba NMA; Stalin Raj V; Haagmans BL
    One Health; 2017 Jun; 3():11-16. PubMed ID: 28616497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.
    Muthumani K; Falzarano D; Reuschel EL; Tingey C; Flingai S; Villarreal DO; Wise M; Patel A; Izmirly A; Aljuaid A; Seliga AM; Soule G; Morrow M; Kraynyak KA; Khan AS; Scott DP; Feldmann F; LaCasse R; Meade-White K; Okumura A; Ugen KE; Sardesai NY; Kim JJ; Kobinger G; Feldmann H; Weiner DB
    Sci Transl Med; 2015 Aug; 7(301):301ra132. PubMed ID: 26290414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Hemida MG; Elmoslemany A; Al-Hizab F; Alnaeem A; Almathen F; Faye B; Chu DK; Perera RA; Peiris M
    Transbound Emerg Dis; 2017 Apr; 64(2):344-353. PubMed ID: 26256102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
    Han HJ; Liu JW; Yu H; Yu XJ
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
    Ying T; Li H; Lu L; Dimitrov DS; Jiang S
    Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.
    Pascal KE; Coleman CM; Mujica AO; Kamat V; Badithe A; Fairhurst J; Hunt C; Strein J; Berrebi A; Sisk JM; Matthews KL; Babb R; Chen G; Lai KM; Huang TT; Olson W; Yancopoulos GD; Stahl N; Frieman MB; Kyratsous CA
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8738-43. PubMed ID: 26124093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.
    Jiang L; Wang N; Zuo T; Shi X; Poon KM; Wu Y; Gao F; Li D; Wang R; Guo J; Fu L; Yuen KY; Zheng BJ; Wang X; Zhang L
    Sci Transl Med; 2014 Apr; 6(234):234ra59. PubMed ID: 24778414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing the MERS coronavirus threat.
    Haagmans BL; Osterhaus AD
    Sci Transl Med; 2014 May; 6(235):235fs19. PubMed ID: 24807556
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.